← Leaderboards
Jinsong Liu
University Of Tx Md Anderson Can Ctr
$2,476,553
Attributed
$2,476,553
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $255.6K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,476,553 · 3
By mechanism
R01$1,262,862 · 1
P50$1,213,691 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Guillermina Lozano$24,537,407
- Ronald Anthony Depinho$97,148,322
- Jonathan M Kurie$24,221,061
- Michael Davies$11,575,720
- Russell R Broaddus$6,374,452
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorSpecimenOvarianMalignant Neoplasm Of OvaryFemale Genital NeoplasmsFreezingFrozen SectionsDiagnosisExperimental DesignsEvaluationCodeFeasibility StudiesBenignFormalinBiopsy SpecimenConsultClinical DataAscitesAwardDatabasesEndometriumCancer CenterCareerArchives
Grant awards (11)
Pathology Core$201,310
P50 · FY2025 · CA · contact PI
Pathology Core$232,828
P50 · FY2024 · CA · contact PI
Pathology Core$225,990
P50 · FY2023 · CA · contact PI
Core 1: Pathology Core$214,844
P50 · FY2021 · CA · contact PI
Core 1: Pathology Core$219,678
P50 · FY2020 · CA · contact PI
Core 1: Pathology Core$119,041
P50 · FY2019 · CA · contact PI
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression$247,971
R01 · FY2012 · CA · contact PI
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression$247,971
R01 · FY2011 · CA · contact PI
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression$255,640
R01 · FY2010 · CA · contact PI
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression$255,640
R01 · FY2009 · CA · contact PI
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression$255,640
R01 · FY2008 · CA · contact PI